This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,209.49, is for the delivery of ondansetron ODT 4 mg tablets. It is a firm fixed-price contract that runs through January 23, 2025. The contract was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,935.36, is for the delivery of Ondansetron ODT 4 mg tablets. The contract has a completion date of January 23, 2025 and utilizes a firm fixed price pricing type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,119.42, is for the delivery of Ondansetron ODT 4 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ondansetron ODT 4 mg tablets for a total ceiling value of $5,488.01. The order has a firm fixed price and an ultimate completion date of August 27, 2024. AmerisourceBergen has a large Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,901.27, is for the delivery of Ondansetron ODT 4 mg tablets. It is a firm fixed-price contract with a completion date of March 12, 2024. The contract is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,304.98 and is for the delivery of Ondansetron ODT 4 mg tablets. The contract is a firm fixed-price delivery order, with a period of performance through May 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,644.13, is for the supply of Ondansetron ODT 4 mg tablets to support military healthcare programs. The contract has a firm fixed price pricing type and a completion date of June 20, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,967.37, is for the delivery of ondansetron ODT 4 mg tablets. The contract is a firm fixed price type and has a completion date of November 28, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,816.52, is for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 tablets per bottle. The contract is a firm fixed-price, delivery order with an ultimate completion date of February 11, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The $8,245.50 firm fixed price contract has an ultimate completion date of August 13, 2024. It is not a set-aside contract. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies for providing a wide range of pharmaceutical and medical products to support...